Lyme disease. What's the big deal?

Crazy, Strange, Creatures Found.

When Muppets Attack: Strange Creature Found in Namibia

Think you've seen it all when it comes to strange creatures out there in the world? Think again. Adelaide Now reports that a strange, muppet-like creature was recently shot by Namibian hunters.

Watch Now

What may seem something of a hoax at first, the creature pictured above was was actually stumbled upon by a hunting party while out searching the dense jungle around the African country. Upon seeing it one hunter shot and wounded it while it was apparently out foraging for food, at which point it ran off.

Following the creature the rest of the party stumbled upon what appeared to be a den of some sort with other similar creatures. Once cornered the wounded one attacked the hunters and was killed while the other creatures ran off.

Nobody is quite sure what to make of this new creature, though its body is being examined by local authorities to determine just what it may be.

Until a full report can be made just be careful to watch out for other muppets in the trees should you be heading outside these days.

source: http://www.heavy.com/news/2012/11/when-muppets-attack-strange-creature-found-in-namibia/

Cascade Monster

Known as the Cascade Monster, this clip of what could be a blob that is undiscovered ventures right past a camera. Like if you think it is a living creature, dislike if you think it is simply just whale blubber or something else!

Strange sea creature or intestines found in the Baltic Sea

July 26, 2012 at 3:14

The Baltic Sea may be the breeding ground for strange creatures or just a place where false rumors are harbored.

The latest in a line of strange sightings is a squirming creature that is dubbed by some as the “Loch Ness Condom.”

The convulsing, ravel of a tubular pink object with transparent yellow membranes connecting its parts was found by German dock employees on April 19, 2011, according to the Huffington Post. The video has since gone viral.

Social sites have gone crazy with their explanations and questions about the strange object.  From humorous accounts on YouTube of it being an “alien sausage” and “flying spaghetti monster” to more serious speculations that it is “loops of bowel with the mesentery and blood supply attached”- this unidentified object is definitely causing a stir.

And speaking of stir, people are clueless as to why intestines would move unless it is indeed a sea creature. A reasoning YouTube speculator notes that the strange convulsing may be “peristaltic waves” and that a brine solution is responsible for the “prolonged contraction.”

Still the theory about it being a sea creature is not entirely out of the question. Many strange creatures such as giant pyrosomes and salps have been found way out in the deep.

This will probably not be the last in a line of unanswered questions from the Baltic Sea. Just a couple of months ago, a sonar detected an unusual disk-shaped object that people suspected was a UFO. That question still has not been answered. If this object is proved to be a sea creature it may join the ranks of these other exotic creatures found in the sea.

source: http://blog.timesunion.com/hottopics/strange-sea-creature-or-intestines-found-in-the-baltic-sea/11434/

NOTE ON THE FOLLOWING...

LYME COMES FROM PLUM ISLAND OFF OF LYME CONNECTICUT WHERE THEY DO TESTING ON ANIMALS, DEVELOPING BIO WARFARE AGENTS AND THOSE ANIMALS THAT...I'M ASSUMING...TRY TO ESCAPE ARE THE ONES THAT HAVE WASHED ON TO SHORE IN NEARBY AREAS AND IN SOME AREAS THAT ARE A BIT FURTHER.

Mysterious Montauk Monster Found Dead on Seal Beach And Other Weird Creature Sightings in 2012

Did you think that you’ve heard your share of news about Montauk monsters? Well think again cause a new corpse from a weird creature washed up on shore on Seal Beach and it looks extremely gruesome.

This unidentified creature was found dead on the beach and at a first glance, it looks like nothing you’ve ever seen before, and so do the other strange creatures sighted in 2012.

The animal had sharp, enormous teeth, but it was hairless, and had no eyes. The animal was found by Karen Summers who was out on the beach enjoying her daily walk. The woman was shocked to see this beastly animal and immediately called the authorities.

Sadly, the officials from the Public Works Department were not able to identify the mysterious animal and buried it, leaving us to wonder what this grotesque animal was.

Read more: http://www.vyperlook.com/odd-strange/corpse-of-weird-creature-washes-up-on-seal-beach#ixzz2E0XZ9Mpx

Montauk Monster

Found along the beach in Milford, CT.

Montauk Monster

Source: Montauk Monster 

Read more: http://www.businessinsider.com/manhattan-east-river-montauk-monster-denise-ginley-2012-7?op=1#ixzz2E1QSckaP

Found on the beach in New London, CT.

Montauk Monster

Source: Montauk Monster

Read more: http://www.businessinsider.com/manhattan-east-river-montauk-monster-denise-ginley-2012-7?op=1#ixzz2E1R2cI1A

Found on Silver Sands Beach in Milford, CT in 2010.

Montauk Monster

Source: Montauk Monster

Read more: http://www.businessinsider.com/manhattan-east-river-montauk-monster-denise-ginley-2012-7?op=1#ixzz2E1RPYIFo

Found Feb. 20, 2012, at Heather Hill, a beach south of Montauk Point.

Read more: http://www.businessinsider.com/manhattan-east-river-montauk-monster-denise-ginley-2012-7?op=1#ixzz2E1RjaKJw

Found April 2009 in Old Lyme, CT. According to the eyewitness, "The police had showed up to check out the site, and shortly after there were men in unusual uniform who came to take the specimen away."

Montauk Monster

Source: Montauk Monster 

Read more: http://www.businessinsider.com/manhattan-east-river-montauk-monster-denise-ginley-2012-7?op=1#ixzz2E1RzQoG9

Romney Sways Voters & is Now on Track!

Romney now on track

By Jennifer Rubin

Mitt Romney leads President Obama in national polls, and the president is approaching his all-time low in the RealClearPolitics average. Romney leads in some key swing states (e.g., Florida, Colorado and North Carolina) and has largely erased the deficit in others (Ohio, Virginia, Nevada). His approval rating (the likability rating so many liberals have obsessed about) is in positive territory; the gap between the two candidates’ approval ratings has all but disappeared.

Obama is below 60 on Intrade. Crowds for Romney and Rep. Paul Ryan (R-Wis.) are swelling in battleground states like Ohio. The Associated Press reported:

The crowds tell the story. As Election Day nears, Mitt Romney is drawing large and excited throngs. Look to dusty Iowa cornfields, rain-soaked Virginia parks, the muddy fields of the Shelby County Fairgrounds, where a crowd of 9,500 — almost half of this western Ohio town — gathered among the barns and stables on a frigid October evening this week to glimpse the Republican presidential contender. . . . He drew an estimated 12,000 people to a central Florida rally last weekend, 1,200 to an Iowa town of just 1,000, and several hundred more to Newport News, Va., under heavy October rain.

“People wonder why it is I’m so confident we’re going to win. I’m confident because I see you here on a day like this. This is unbelievable,” Romney said, his wet hair stuck to the side of his face. Soaked supporters standing in muddy puddles cheered as he delivered an abridged version of his standard campaign speech. Some wore ponchos, while many others stood shivering and drenched, hands in pockets.

This is all the more remarkable since Romney was never the favorite of the right-wing base.

The New York Times grudgingly concedes that Romney continues to surge. His “bounce” from the Oct. 3 debate hasn’t faded. His state polling in swing states has followed his national surge.

All of this suggests that the presidential race changed in some fundamental way after the first debate. It can certainly change again, but it is silly to deny that the first debate has been more significant than any one event in the 2012 election.

What happened? For one thing the debate exposed what many Republicans suspected, namely that some of Obama’s support was shallow, rooted in habit or from failure to consider Romney might be a viable alternative. Even in the heady days after the Democratic National Convention Obama did not reach more than 50 percent in the RCP averages or even in any week of Gallup tracking polls.

Recall that virtually the entire Obama strategy was aimed to discredit and delegitimize Romney as a candidate. The avalanche of negative ads in the summer, however, failed (barely) to do so. With Romney’s extraordinary debate performance, it now becomes nearly impossible to vilify him. Unfortunately for Obama he’s got no Plan B. He never devised an impressive second-term agenda. He has either unpopular (Obamacare) or unhelpful (raise taxes) or small beans (hire 100,000 teachers) proposals. Romney has therefore been able to deploy his “we can’t afford four more years” argument quite effectively.

And finally, as many of us suspected, foreign policy has become a front-burner issue. The attack on the Benghazi Consulate has now resonated with mainstream media and has become a story about competence and credibility. This may not have contributed to Romney’s rise, but it will assist him in holding off Obama.

For this, Romney owes a debt of gratitude to Vice President Biden, who elevated the issue in the debate through blatant misstatements. And in pointing the finger at the intelligence community, Biden risks a backlash in the form of leaks and testimony from those who aren’t going to take the fall for politicians. James Risen of the New York Times picks up on just one story line that just weeks ago hadn’t garnered much attention, as he writes:

The large private security firms that have protected American diplomats in Iraq and Afghanistan sought State Department contracts in Libya, and at least one made a personal pitch to the ambassador, J. Christopher Stevens, who was killed in the militants’ attack in Benghazi on Sept. 11, according to a senior official at one firm.

But given the Libyan edict banning the contractors, the Obama administration was eager to reduce the American footprint there. After initially soliciting bids from major security companies for work in Libya, State Department officials never followed through.

“We went in to make a pitch, and nothing happened,” said the security firm official. He said the State Department could have found a way around the Libyans’ objections if it had wanted to.

Be prepared to see the drip-drip-drip of more revelations as whistleblowers get in line to tell their side of the story.

Romney has not won this race yet. A rotten debate performance could reset the race once more. Obama and his Chicago political hacks may have an October surprise or two up their collective sleeves. But now time and momentum are on Romney’s side. He appears to a plurality of voters to be not just an alternative to Obama but a good one. Unless that changes and changes fast (remember early voting is ongoing), Romney will win.

source: http://www.washingtonpost.com/blogs/right-turn/post/romney-now-on-track/2012/10/13/ec6e1ef2-153b-11e2-ba83-a7a396e6b2a7_blog.html

Addressing Attacks Against Mitt Romney Regarding Attempt to Improve Lyme Care in Virginia

As most people might guess, I have Lyme Disease. I’ve had it for 10 years now. I’m not here to defend Romney or endorse him. I’m here to explain how sad it is that few media outlets are focusing on the real issue. And that’s Lyme Disease, the epidemic.

At this point, I could care less what Mitt’s intent is for that Virginia mailer.  We can speculate all we want, but why? We aren’t Romney or his team of brains that think up his campaign tactics. I do, however, think this is a good chance to view exactly how divided science, politics, the medical industry and patients are on this ONE topic.

Whether citizens in any one of these populations of people care to admit or not (if they even have an inkling), this disease is currently the largest vector-borne disease in America. Much like HIV was dubbed the “gay man’s disease” in the 80′s, Chronic Lyme Disease is getting ridiculed, overlooked, and dismissed without much attempt at further scientific research, aside from privately funded studies.

Why is this a political disease? Ask the politicians. Between Dearborn, OSP A and Plum Island, I’d say there is a whole lot of room for investigation. Of course, mainstream readers aren’t going to be reading about those topics, because the media has presented a neat and tidy scenario that makes Lyme activists, much like myself, “conspiracy theorists”.

I could care less about the criminals involved with creating this controversy. They will receive their Karma when they are ready to learn about the receiving end of disease. Whether they learn in this lifetime or the next is not up to me, but them, if you believe in that sort of thing. That’s really not my concern. Right now, Lyme patients need help. We need science. We need better (more sensitive) testing, we need treatments that WORK. Government has done nothing to support scientific research in chronic lyme disease.

Online “science” and news blogs are directing their attention on the WRONG thing. Forget about Romney for a second. Forget about what you think you know about this disease. Ask George W. Bush if he went to an IDSA trained doctor for his Lyme disease. Ask Bush how long he treated his infection. ANSWER: longer than 4 weeks, which is the max amount of time given to non-presidential Lyme patients with a newly diagnosed case only. Anything longer than that, you’re on your own.

What is being attempted by Romney is beyond description.LymeDisease.org explains it best in their blog post.

In there they discuss how Durland Fish, one of the IDSA authors, firmly believes Chronic Lyme Disease doesn’t exist. Where is the scientific evidence that it doesn’t exist? Where are the scientific studies the proves 4 weeks of doxycycline cures Lyme Disease? THAT is what doesn’t exist, because it’s never been done. What Mr. Fish IS good at is yelling at peaceful IDSA Guideline protesters, claiming they are “all crazy” and “you don’t know what you’re talking about,” while he flailed his arms about in a demeaning manner. What was he so upset about, if he has science backing his (flawed) guidelines up? 

Unfortunately, mass media is going to support what the “authorities” say and label it as truth, while grouping Romney with the rest of the “quacks” in support of Lyme Disease awareness, prevention and proper treatment. Epidemic monsters like Lyme Disease cannot be kept in the closet forever. The US government knows this. The IDSA knows this. It’s a matter of what will they do to make themselves look like the heroes when they have no choice but to address these very real concerns.

If you want to understand the Lyme epidemic and the issues within the divided medical community, read “Cure Unknown”  by Pamela Weintraub. She’s a talented and objective medical science journalist who happened to have Lyme after moving to upstate New York, along with her husband and children. The disease is devastatingly real. Some of these “writers” on these “science” and political news blogs (see links below) could really benefit by learning how to become self-thinking humans. It’s really not entirely difficult. All you need is a spine, a brain, and some balls.

read more here http://mylymechronicle.com/2012/10/01/532/

What Did The FDA Rule On Testing New Drug For Chronic Lyme?

So, if there isn't late-stage or chronic Lyme disease, why would the FDA rule on a new drug to treat chronic Lyme?  I have chronic Lyme or late-stage Lyme and we are literally dying to receive a drug treatment.  I have scoured the Internet and the following is the only information I could find.  I could not find the ruling anywhere.

----------------------------------------------------------

FDA to Rule on Testing New Drug for Chronic Lyme

PRWeb

Published 10:15 a.m., Monday, April 2, 2012

Researchers led by Time for Lyme grantee, M. Karen Newell-Rogers, Ph.D, have submitted a pre-IND briefing document to the US Food and Drug Administration, a preliminary step toward developing proposals for clinical testing of a new drug that could one day end the suffering of those with chronic, or long-term Lyme disease.

Stamford, CT (PRWEB) April 02, 2012

“To our knowledge this is the first novel drug candidate that has been proposed for study in the treatment of chronic Lyme Disease post-infection in some time,” said a representative of Viral Genetics, that submitted the proposal for its drug candidate, VGV-L, to the FDA. A response is expected in April.

Tests led by Dr. Newell-Rogers, a professor at Texas A&M Health Science Center College of Medicine and Scott & White Hospital, and a scientific advisor to Viral Genetics, have been conducted for over two and a half years. The results were submitted this month to the FDA, along with a protocol for a proposed human clinical trial designed under the guidance of a leading Lyme clinician at one of the nation’s top medical centers. Testing to date was conducted by Dr. Newell-Rogers with significant contributions from other clinicians at the University of Colorado, Texas A&M Health Science Center and Scott & White Hospital in Texas.

Prior research had established the insight that certain immune characteristics may contribute to whether a person is susceptible or resistant to the development of chronic inflammation as a result of infection. Dr. Newell-Rogers theory proposes a “targeted” peptide to replace or remove the self-peptides and restore a healthy immune response in patients.

Much of the funding for the pre-clinical studies leading to the FDA filing was provided by Time for Lyme, acting in concert with Richard Gerstner, the ex-IBM Executive VP who saw the potential applicability of Dr. Newell’s work, to Lyme disease.

Time for Lyme has raised over $5 million since its founding in 1998 to fund research on Lyme and other tick-borne diseases at esteemed institutions across the U.S., including the establishment and endowment of Columbia University Medical Center’s Lyme and Tick-borne Disease Research Center.

“Time for Lyme is focused on its clear and single mission of promoting research into Lyme and tick borne diseases,” said Peter Wild, executive director of the organization. “At present there is no recognized treatment for Lyme once it has developed into its chronic, long-term state. We are hopeful that Dr. Newell-Roger’s work will provide the solution that long-term Lyme disease sufferers have been hoping for, for decades.”

Read more: http://www.timesunion.com/business/press-releases/article/FDA-to-Rule-on-Testing-New-Drug-for-Chronic-Lyme-3452046.php#ixzz1v9bZwPXy

Press Release
Source: Viral Genetics, Inc.
Viral Genetics Publishes March 2012 Monthly Letter to Shareholders.
Cites Pre-IND Filing with FDA for Lyme Disease, Other Drugs in Pipeline & Progress in Algal BioFuel Subsidiary, VG Energy
Business WireSan Marino, CA (PRWEB) March 14, 2012
Viral Genetics (Pinksheets: VRAL.PK - News) today published its March 2012 Letter to Shareholders. Providing updates on the company’s progress, the letter discusses the recent Pre-IND filing for its Lyme Disease drug candidate, notes other drugs in the pipeline that have developed out of the company’s Metabolic Disruption Technology Platform, and talks about progress in proving the efficacy of the yield enhancement in the company’s algal biofuels subsidiary, VG Energy.
The letter is available on the company’s website at http://www.viralgenetics.com/shareholder-letters/Letter-to-Shareholders-Mar-12.PDF.
About Viral Genetics, Inc.
San Marino, California-based Viral Genetics discovers drug therapies from two platform technologies based on over 60 patents: Metabolic Disruption (MDT) and Targeted Peptides (TPT). Founded in 1994, the biotech company is researching treatments for HIV/AIDS, Lyme Disease, Strep, Staph and drug resistant cancer. A majority-owned subsidiary, VG Energy (www.vgenergy.net), is dedicated to exploring biofuel and agricultural applications for the MDT platform. For more information, visit www.viralgenetics.com.
About VG Energy
VG Energy Inc. is an alternative energy and agricultural biotech company that is a majority-owned subsidiary of Viral Genetics Inc. Using its Metabolic Disruption Technology (MDT), Viral Genetics' cancer research led to discoveries with major consequences in a wide variety of other industries, including production of biofuel and vegetable oils. VG Energy holds the exclusive worldwide license to the MDT patent rights for use in the increase of production of various plant-derived oils from algae and seeds. Application of MDT technology to the biofuel industry could potentially allow it to overcome its major obstacle in the area of production efficiency: namely, an increase in production yields leading to feasible economic returns on investment, allowing renewable biodiesel to be competitive with fossil fuels. For more information, please visit www.vgenergy.net.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical trials, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports, including statements about its VG Energy, Inc. subsidiary. None of Viral Genetics' drug compounds are approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world, nor are any non-pharmaceutical products of VG Energy, Inc. commercialized. While Viral Genetics believes that the forward-looking statements and underlying assumptions are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Viral Genetics to establish the efficacy of any of its drug therapies in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of those drug compounds in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests including clinical trials on time or at all, the successful outcome of such studies or tests, or the successful commercialization of VG Energy, Inc.’s non-pharmaceutical products. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by Viral Genetics or any other person that the objectives and plans of Viral Genetics will be achieved. 
Contact:BlueWater Advisory Group, LLCBryan Crane, 805-294-3723
Contact:Viral Genetics, Inc.Haig Keledjian, 626-334-5310 
Click here to return to our Press Release selection page.